Home
Conditions
Recurrent Mantle Cell Lymphoma

Clinical trial condition

Recurrent Mantle Cell Lymphoma

Explore clinical trials studying Recurrent Mantle Cell Lymphoma. Study availability and eligibility vary by location and protocol.

147 public trials 8 recruiting studies

Refine in advanced search Browse all conditions

Recurrent Mantle Cell Lymphoma trial results

Completed

Genetically Engineered Lymphocytes, Cyclophosphamide, and Aldesleukin in Treating Patients With Relapsed or Refractory Mantle Cell Lymphoma or Indolent B-Cell Non-Hodgkin Lymphoma

NCT00621452

Conditions: B-cell Chronic Lymphocytic Leukemia, Blood Protein Disorders, Cardiovascular Diseases, +38 more
Locations: Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium Seattle, Washington, United States

View Trial Details

Completed

Iodine I 131 Tositumomab and Fludarabine Phosphate in Treating Older Patients Who Are Undergoing an Autologous or Syngeneic Stem Cell Transplant for Relapsed or Refractory Non-Hodgkin's Lymphoma

NCT00110071

Conditions: Blood Protein Disorders, Burkitt Lymphoma, Cardiovascular Diseases, +46 more
Locations: Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium Seattle, Washington, United States

View Trial Details

Completed

17-AAG in Treating Patients With Relapsed or Refractory Anaplastic Large Cell Lymphoma, Mantle Cell Lymphoma, or Hodgkin's Lymphoma

NCT00117988

Conditions: Anaplastic Large Cell Lymphoma, Hemic and Lymphatic Diseases, Hodgkin Disease, +13 more
Locations: M D Anderson Cancer Center Houston, Texas, United States

View Trial Details

Completed

Oblimersen Sodium and Rituximab in Treating Patients With Recurrent B-cell Non-Hodgkin Lymphoma

NCT00054639

Conditions: Blood Protein Disorders, Burkitt Lymphoma, Cardiovascular Diseases, +60 more
Locations: M D Anderson Cancer Center Houston, Texas, United States

View Trial Details

Completed

Ixabepilone in Treating Patients With Relapsed or Refractory Aggressive Non-Hodgkin's Lymphoma

NCT00058019

Conditions: Anaplastic Large Cell Lymphoma, Burkitt Lymphoma, DNA Virus Infections, +25 more
Locations: University of Chicago Chicago, Illinois, United States

M D Anderson Cancer Center Houston, Texas, United States

View Trial Details

Completed

MK2206 in Treating Younger Patients With Recurrent or Refractory Solid Tumors or Leukemia

NCT01231919

Conditions: Accelerated Phase Chronic Myelogenous Leukemia, Acute Leukemias of Ambiguous Lineage, Acute Myeloid Leukemia/Transient Myeloproliferative Disorder, +130 more
Locations: University of Alabama at Birmingham Birmingham, Alabama, United States

Childrens Hospital of Orange County Orange, California, United States

University of California San Francisco Medical Center-Parnassus San Francisco, California, United States

Children's National Medical Center Washington D.C., District of Columbia, United States

View all 25 locations

View Trial Details

Completed

CCI-779 and Rituximab in Treating Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma

NCT00109967

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +8 more
Locations: Mobile Infirmary Medical Center Mobile, Alabama, United States

The Medical Center of Aurora Aurora, Colorado, United States

Boulder Community Hospital Boulder, Colorado, United States

Penrose-Saint Francis Healthcare Colorado Springs, Colorado, United States

View all 195 locations

View Trial Details

Completed

CCI-779 in Treating Patients With Mantle Cell Non-Hodgkin's Lymphoma

NCT00033267

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +8 more
Locations: North Central Cancer Treatment Group Rochester, Minnesota, United States

View Trial Details

Completed

Palifermin in Preventing Chronic Graft-Versus-Host Disease in Patients Who Have Undergone Donor Stem Cell Transplant for Hematologic Cancer

NCT01233921

Conditions: Accelerated Phase Chronic Myelogenous Leukemia, Adult Acute Lymphoblastic Leukemia in Remission, Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities, +151 more
Locations: Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium Seattle, Washington, United States

View Trial Details

Completed

Sunitinib Malate in Treating HIV-Positive Patients With Cancer Receiving Antiretroviral Therapy

NCT00890747

Conditions: AIDS-related Diffuse Large Cell Lymphoma, AIDS-related Diffuse Mixed Cell Lymphoma, AIDS-related Diffuse Small Cleaved Cell Lymphoma, +199 more
Locations: Jonsson Comprehensive Cancer Center Los Angeles, California, United States

Lombardi Comprehensive Cancer Center at Georgetown University Washington D.C., District of Columbia, United States

Northwestern University Chicago, Illinois, United States

AIDS - Associated Malignancies Clinical Trials Consortium Rockville, Maryland, United States

View Trial Details

Recurrent Mantle Cell Lymphoma

Recurrent Mantle Cell Lymphoma trial results

Related conditions